Nonmyeloablative allogeneic hematopoietic stem cell transplantation for treatment of Dyskeratosis congenita

Bone Marrow Transplantation

Volumn 31, Issue 5, 2003, Pages 407-410

  Gungor T ^a   Corbacioglu, S ^a   Storb, R ^b   Seger, R A ^a  

^a UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Combined immunodeficiency; Dyskeratosis congenita; Hematopoietic stem cell transplantation (HSCT); Hoyeraal Hreidarsson syndrome; Non myeloablative stem cell transplantation

Indexed keywords

ANTITHROMBIN III CONCENTRATE; CANDIDIN; CD19 ANTIGEN; CD4 ANTIGEN; CD45 ANTIGEN; CD8 ANTIGEN; COTRIMOXAZOLE; CYCLOSPORIN A; FLUDARABINE; GRANULOCYTE COLONY STIMULATING FACTOR; HEPARIN; IMMUNOGLOBULIN G; IMMUNOSUPPRESSIVE AGENT; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PHYTOHEMAGGLUTININ; PNEUMOCOCCUS VACCINE; TETANUS TOXOID;

ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; AUTOSOMAL RECESSIVE DISORDER; B LYMPHOCYTE; BLOOD CELL COUNT; CASE REPORT; CELL LINEAGE; CHIMERA; COMBINED IMMUNODEFICIENCY; DOSE RESPONSE; DRUG EFFICACY; DRUG SAFETY; DYSKERATOSIS CONGENITA; FEMALE; FLUORESCENCE ACTIVATED CELL SORTING; GRAFT VERSUS HOST REACTION; HAIR LOSS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HLA MATCHING; HUMAN; IMMUNOPROPHYLAXIS; LEUKOPLAKIA; LIVING DONOR; LUNG FUNCTION; LYMPHOCYTE FUNCTION; LYMPHOCYTOPENIA; MUCOSA INFLAMMATION; NAIL DYSTROPHY; NEUROLOGIC EXAMINATION; NEUTROPENIA; PERIPHERAL BLOOD STEM CELL; PNEUMOCYSTIS PNEUMONIA; PRIORITY JOURNAL; RADIATION DOSE; SCHOOL CHILD; T LYMPHOCYTE; THROMBOCYTOPENIA; VEIN OCCLUSION; WHOLE BODY RADIATION;

CHILD; DYSKERATOSIS CONGENITA; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, HOMOLOGOUS;

EID: 0037356063     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1703844     Document Type: Article

References (15)

1. Dokal I. Dyskeratosis congenita in all its forms. Br J Haematol 2000; 110: 768-779.
2. Lee BW, Yap HK, Quah TC et al. T cell immunodeficiency in dyskeratosis congenita. Arch Dis Child 1992; 67: 524-526.
3. Heiss NS, Knight SW, Vulliamy TJ et al. X-linked dyskeratosis congenita is caused by mutations in a highly conserved gene with putative nucleolar functions. Nat Genet 1998; 19: 32-38.
4. Knight SW, Heiss NS, Vulliamy TJ et al. Unexplained aplastic anaemia, immunodeficiency, and cerebellar hypoplasia (Hoyeraal-Hreidarsson syndrome) due to mutations in the dyskeratosis congenita gene, DKC1. Br J Haematol 1999; 107: 335-339.
5. Vulliamy T, Marrone A, Goldman F et al. The RNA component of telomerase is mutated in autosomal dominant dyskeratosis congenita. Nature 2001; 413: 432-435.
6. Blasco MA, Lee HW, Hande MP, Samper E et al. Telomere shortening and tumor formation by mouse cells lacking telomerase RNA. Cell 1997; 91: 25-34.
7. Rocha V, Devergie A, Socie G et al. Unusual complications after bone marrow transplantation for dyskeratosis congenita. Br J Haematol 1998; 193: 243-248.
8. Yabe M, Yabe H, Hattori K et al. Fatal interstitial pulmonary disease in a patient with dyskeratosis congenita after allogeneic bone marrow transplantation. Bone Marrow Transplant 1997; 19: 389-392.
9. Knight S, Vulliamy T, Copplestone A et al. Dyskeratosis Congenita (DC) Registry: identification of new features of DC. Br J Haematol 1998; 103: 990-996.
10. Berthet F, Caduff R, Schaad UB et al. A syndrome of primary combined immunodeficiency with microcephaly, cerebellar hypoplasia, growth failure and progressive pancytopenia. Eur J Pediatr 1994; 153: 333-338.
11. Carella AM, Champlin R, Slavin S et al. Mini-allografts: ongoing trials in humans. Bone Marrow Transplant 2000; 5: 345-350.
12. McSweeney PA, Niederwieser D, Shizuru JA et al. Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects. Blood 2001; 97: 3390-3400.
13. Amrolia P, Gaspar HB, Hassan A et al. Nonmyeloablative stem cell transplantation for congenital immunodeficiencies. Blood 2000; 15: 1239-1246.
14. Kliem C, Hegenbart U, Maris M et al. Low mycophenolate mofetil (MMF) draft serum levels correlate with the occurrence of acute GvHD grades II-IV after allogeneic hematopoietic stem cell transplantation (HSCT) following low dose TBI with/without fludarabine and immunosuppression with CyA/MMF. Bone Marrow Transplantation 2002; 29 (Suppl.): 148.
15. Debauch DM, Pai GS, Stanley WS. Enhanced G2 chromatid radiosensitivity in dyskeratosis congenita. Am J Hum Genet 1990; 46: 350-357.